These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Beta interferons for multiple sclerosis. Med Lett Drugs Ther; 2002 Oct; 44(1141):88-9. PubMed ID: 12381969 [No Abstract] [Full Text] [Related]
7. Interferon beta in multiple sclerosis: how much BENEFIT? Pittock SJ Lancet; 2007 Aug; 370(9585):363-4. PubMed ID: 17678997 [No Abstract] [Full Text] [Related]
8. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta. McDonald WI; Miller DH; Thompson AJ Ann Neurol; 1994 Jul; 36(1):14-8. PubMed ID: 8024255 [No Abstract] [Full Text] [Related]
9. [A short history of beta-interferon therapy of multiple sclerosis]. Stock G; Horowski R Med Klin (Munich); 2001 Sep; 96 Suppl 1():3-9. PubMed ID: 11603113 [TBL] [Abstract][Full Text] [Related]
10. [Interferon-beta treatment of progressive disseminated sclerosis. Is it possibly without effect?]. Foldspang A Ugeskr Laeger; 1999 Aug; 161(31):4418-21. PubMed ID: 10487112 [No Abstract] [Full Text] [Related]
11. Managing the adverse effects of interferon-beta therapy in multiple sclerosis. Bayas A; Rieckmann P Drug Saf; 2000 Feb; 22(2):149-59. PubMed ID: 10672896 [TBL] [Abstract][Full Text] [Related]
12. Coming of age: the use of immunomodulatory therapy in children with multiple sclerosis. Banwell B; Tremlett H Neurology; 2005 Mar; 64(5):778-9. PubMed ID: 15753408 [No Abstract] [Full Text] [Related]
14. Interferon neutralizing antibodies in multiple sclerosis: a new perspective. Phillips JT Arch Neurol; 2010 Apr; 67(4):386-7. PubMed ID: 20385901 [No Abstract] [Full Text] [Related]
15. Interferon beta-1a and beta-1b for treatment of multiple sclerosis. Kappos L Lancet; 2002 Nov; 360(9343):1428; author reply 1428-9. PubMed ID: 12424020 [No Abstract] [Full Text] [Related]
16. Are clinical trials of therapeutic agents for MS long enough? Rudge P Lancet; 1999 Mar; 353(9158):1033-4. PubMed ID: 10199348 [No Abstract] [Full Text] [Related]
17. Key issues in the diagnosis and treatment of multiple sclerosis. An overview. O'Connor P; Neurology; 2002 Sep; 59(6 Suppl 3):S1-33. PubMed ID: 12448786 [No Abstract] [Full Text] [Related]